NewsRx

Search our medical news database

Diabetes Control

Continuous glucose monitoring effects patients' decisions about type 1 diabetes

Published in Obesity and Diabetes Week, July 11th, 2005

Medtronic, Inc. (MDT) announced results of a pilot study showing participants actively used real-time glucose readings to better control glucose fluctuations.

Diabetes patients in the study used Medtronic's Guardian RT Continuous Glucose Monitoring System to monitor glucose levels throughout the day and night. The system is designed to help patients reduce erratic blood sugar (glucose) fluctuations that can result in diabetes-related complications, including coma, blindness, kidney failure, amputation, impotence and heart disease.

During the 10-day pilot study, 16 patients responded to glucose values as well as high and low alerts displayed on the...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook